Finance

Lists
4155:TPE
OK Biotech Co Ltd
NT$17.55
+1.15%
(+0.20) 1D
Nov 16, 1:30:30 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4155...
Open
NT$18.25
High
NT$18.85
Low
NT$17.55
Mkt. cap
2.20B
Avg. vol.
860.71K
Volume
1.83M
Dividend
1.71%
Quarterly dividend
NT$0.08
Ex-dividend date
Oct 20, 2026
P/E ratio
9.42
52-wk high
NT$18.85
52-wk low
NT$14.34
EPS
NT$1.86
Shares outstanding
74.63M
No. of employees
62
Open
NT$18.25
High
NT$18.85
Low
NT$17.55
Mkt. cap
2.20B
Avg. vol.
860.71K
Volume
1.83M
Dividend
1.71%
Quarterly dividend
NT$0.08
Ex-dividend date
Oct 20, 2026
P/E ratio
9.42
52-wk high
NT$18.85
52-wk low
NT$14.34
EPS
NT$1.86
Shares outstanding
74.63M
No. of employees
62
News stories
From web sources and news partners
About OK Biotech Co Ltd
CEOJames Lai
Employees62
Founded2004
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
337.58M
383.78M
436.13M
565.45M
Cost of goods sold
244.34M
261.14M
305.92M
364.80M
Cost of revenue
244.34M
261.14M
305.92M
364.80M
Research and development expenses
22.76M
8.89M
15.17M
21.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50.12M
60.12M
71.50M
67.41M
Operating expense
36.72M
62.54M
78.54M
75.86M
Total operating expenses
281.06M
323.68M
384.46M
440.66M
Operating income
56.52M
60.10M
51.67M
124.80M
Other non operating income
-1.93M
4.69M
10.59M
-4.04M
EBT including unusual items
69.51M
74.75M
64.00M
120.03M
EBT excluding unusual items
70.99M
75.71M
62.76M
120.03M
Income tax expense
10.36M
11.18M
14.94M
21.32M
Effective tax rate
14.91%
14.96%
23.35%
17.76%
Other operating expenses
-
-
-
-12.70M
Net income
53.54M
55.35M
48.16M
93.97M
Net profit margin
15.86%
14.42%
11.04%
16.62%
Earnings per share
-
-
-
-
Interest and investment income
1.01M
322.00K
2.02M
937.00K
Interest expense
-3.65M
-1.83M
-1.76M
-1.62M
Net interest expenses
-2.64M
-1.51M
262.00K
-681.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
76.42M
80.17M
71.72M
148.13M
Gain or loss from assets sale
294.00K
2.00M
6.00K
20.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps